These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33131917)

  • 41. The role of antisecretory drugs in the treatment of Helicobacter pylori infection.
    Peterson WL
    Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():21-5. PubMed ID: 9146787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Current principles of treatment of acid-dependent diseases].
    Maev IV; V'iuchnova ES; Grishchenko EB
    Klin Med (Mosk); 2003; 81(1):56-62. PubMed ID: 12650099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression?
    Kinoshita Y; Ishihara S
    J Gastroenterol; 2004 Jan; 39(1):92-3. PubMed ID: 14767746
    [No Abstract]   [Full Text] [Related]  

  • 44. A comment on 'the impact of statins, ace inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort'.
    Choi NK; Chang Y; Park BJ
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1121-2. PubMed ID: 19852000
    [No Abstract]   [Full Text] [Related]  

  • 45. Medical management of gastric ulcer.
    LaBrooy SJ
    Ann Acad Med Singap; 1983 Oct; 12(4):548-54. PubMed ID: 6146287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton-pump inhibitors are the treatment of choice in acid-related disease.
    Brunner G
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S9-13. PubMed ID: 8930574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A review of stress-related mucosal disease.
    Monnig AA; Prittie JE
    J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):484-95. PubMed ID: 22316196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stress ulcer prophylaxis: still a valid option in the 1990s?
    Schepp W
    Digestion; 1993; 54(4):189-99. PubMed ID: 7902305
    [No Abstract]   [Full Text] [Related]  

  • 50. Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users.
    Kim TJ; Kim ER; Hong SN; Kim YH; Lee YC; Kim HS; Kim K; Chang DK
    Sci Rep; 2019 Aug; 9(1):11696. PubMed ID: 31406189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.
    Lazzaroni M; Bianchi Porro G
    Dig Liver Dis; 2001 Dec; 33 Suppl 2():S44-58. PubMed ID: 11827362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The new algorithm of diagnostics, prevention and treatment of acute erosive and ulcerative lesions of the gastrointestinal tract].
    Dzhitava IG; Smirnova GO; Martirosov AV
    Eksp Klin Gastroenterol; 2011; (5):63-8. PubMed ID: 21916237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
    Song TJ; Kim J
    PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical therapy of peptic ulcer disease.
    McQuaid KR; Isenberg JI
    Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A cross-sectional study of national outpatient gastric acid suppressant prescribing in the United States between 2009 and 2015.
    Bustillos H; Leer K; Kitten A; Reveles KR
    PLoS One; 2018; 13(11):e0208461. PubMed ID: 30500865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it.
    Hassall E
    J Pediatr; 2012 Feb; 160(2):193-8. PubMed ID: 22018908
    [No Abstract]   [Full Text] [Related]  

  • 59. Concordance between use of proton pump inhibitors and prescribing guidelines.
    Leditschke IA; Coombes JA
    Med J Aust; 2000 Jun; 172(11):564. PubMed ID: 10920757
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K; Sivaramakrishnan G; Gnanaraj J
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.